Coronavirus disease 2019; epidemiology and recommendations

Mousa Ghelichi-Ghojogh ¹ * , Ehsan Allah Kalteh ² , Mohammad Fararooei ³

Cited by CrossRef: 3

1- Feng Z, Pan Y, Liu Y, Zhao J, Peng X, Lu G, Shi W, Zhang D, Cui S. Screening and Analysis of Serum Protein Biomarkers Infected by Coronavirus Disease 2019 (COVID-19). TropicalMed. 2022;7(12):397 [Crossref]

2- Nokhodian Z, Ranjbar M, Nasri P, Kassaian N, Shoaei P, Vakili B, Rostami S, Ahangarzadeh S, Alibakhshi A, Yarian F, Javanmard S, Ataei B. Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment. J Res Med Sci. 2020;25(1):101 [Crossref]

3- Yao W, Dong H, Qi J, Zhang Y, Shi L. Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis. eClinicalMedicine. 2022;51:101545 [Crossref]

4- Mahluji S, Jalili M, Ostadrahimi A, Hallajzadeh J, Ebrahimzadeh-Attari V, Saghafi-Asl M. Nutritional management of diabetes mellitus during the pandemic of COVID-19: a comprehensive narrative review. J Diabetes Metab Disord. 2021;20(1):963 [Crossref]